TIDMHAT

RNS Number : 9206E

H&T Group PLC

14 February 2018

14(th) February 2018

H&T Group plc

("H&T" or "the Group" or "the Company")

Statement regarding Finance Director, Steve Fenerty

The Board of H&T Plc announces that its Finance Director, Steve Fenerty, has recently been diagnosed with leukaemia. He is receiving first class treatment and remains actively involved with the running of the business.

Peter McNamara, Chairman said, "We have a clear strategy headed by CEO John Nichols. Steve Fenerty is well supported by Tatiana Hagan, part of a first class finance team he has developed over recent years. Steve Fenerty will have further assistance given by an interim appointment from an experienced Financial Officer from within the sector.

We all wish Steve well in his treatment and recovery."

- ENDS -

Enquiries:

H&T Group plc

Tel: 0870 9022 600

John Nichols, chief executive

Steve Fenerty, finance director

Numis Securities (broker and nominated adviser)

Tel: 020 7260 1000

Mark Lander, corporate broking

Freddie Barnfield, nominated adviser

Haggie Partners (public relations)

Tel: 020 7562 4444

Damian Beeley

Brian Norris

This information is provided by RNS

The company news service from the London Stock Exchange

END

STRSFEFMLFASEEE

(END) Dow Jones Newswires

February 14, 2018 11:35 ET (16:35 GMT)

H&t (LSE:HAT)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more H&t Charts.
H&t (LSE:HAT)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more H&t Charts.